|1.||Kennedy, J L: 6 articles (01/2004 - 06/2000)|
|2.||Wang, Yufeng: 3 articles (01/2013 - 08/2003)|
|3.||Qian, Qiujin: 3 articles (01/2013 - 08/2003)|
|4.||Sasvári-Székely, Mária: 3 articles (03/2010 - 03/2005)|
|5.||Lung, For-Wey: 3 articles (03/2010 - 08/2006)|
|6.||Ronai, Z: 3 articles (12/2007 - 06/2000)|
|7.||Sasvari-Szekely, M: 3 articles (12/2007 - 06/2000)|
|8.||Yang, Li: 3 articles (06/2007 - 08/2003)|
|9.||Zhang, Kehong: 3 articles (08/2004 - 04/2002)|
|10.||Tarazi, Frank I: 3 articles (08/2004 - 04/2002)|
|1.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/01/2008 - "A moderating role of the dopamine D4 receptor (DRD4) variable-number tandem repeat (VNTR) exon III polymorphism was found: VIPP-SD proved to be effective in decreasing externalizing behavior in children with the DRD4 7-repeat allele, a polymorphism that is associated with motivational and reward mechanisms and Attention Deficit Hyperactivity Disorder (ADHD) in children. "
09/01/2009 - "The aim of this study was to evaluate the association between a variable number of tandem repeats polymorphism at the dopamine D4 receptor gene (DRD4) and the performance of children with attention deficit hyperactivity disorder (ADHD) in a continuous performance test (CPT). "
01/01/2008 - "Recent genetic studies at the 5' end of the dopamine D4 receptor (DRD4) gene have identified several polymorphisms having a possible relationship with attention deficit-hyperactivity disorder (ADHD). "
05/01/2005 - "This study was designed to investigate the link among attention deficit hyperactivity disorder (ADHD) in adults, novelty-seeking temperament, and the 48-base pair (bp) dopamine D4 receptor (DRD4) gene variant. "
11/01/2004 - "This study investigated the relationship between dopamine D4 receptor gene polymorphism, temperament categories, and attention deficit hyperactivity disorder in 81 children with the disorder and 24 control subjects. "
|2.||Schizophrenia (Dementia Praecox)
12/03/2007 - "In this study, we investigated whether polymorphisms of the dopamine D4 receptor (DRD4) gene were associated with psychotic symptomatology rather than with a unique diagnosis such as schizophrenia. "
02/15/2004 - "Alterations in dopaminergic system have been implicated in the pathophysiology of this disease for many years, and this study was performed to assess the possible involvement of the dopamine D4 receptor (DRD4) gene polymorphisms either in the 5' upstream or in the coding regions, in the etiology of schizophrenia. "
01/01/2001 - "The human dopamine D4 receptor (DRD4) is of major interest in molccular studies of schizophrenia and personality traits. "
10/09/1995 - "Association study between the dopamine D4 receptor gene and schizophrenia."
03/15/1994 - "We report the results of a linkage study in 24 families multiply affected with schizophrenia using a polymorphic DNA sequence encoding the third cytoplasmic loop of the dopamine D4 receptor. "
|5.||Mood Disorders (Mood Disorder)
08/17/1998 - "In this study, we investigated the possibility that functional variants of the dopamine D4 receptor (DRD4) gene might be associated with depressive symptomatology in a sample of mood disorder subjects. "
05/17/1995 - "In addition to the linkage approach, we have undertaken an allelic association study using 74 patients with affective disorder and 78 controls with polymorphisms at the TH gene and the nearby dopamine D4 receptor gene. "
05/01/2005 - "We conducted a meta-analysis to re-evaluate the role of the dopamine D4 receptor gene 48-base-pair- repeat (DRD4) polymorphism in mood disorders. "
05/01/2005 - "The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis."
09/09/1996 - "Our results suggest that there is a significant association between the dopamine D4 receptor gene and mood disorders, especially major depression, but no association between the other polymorphisms and mood disorders. "
|1.||3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridine
|5.||Levodopa (L Dopa)
|6.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|7.||Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
|8.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|9.||Dopamine D2 Receptors (Dopamine D2 Receptor)
|2.||Drug Therapy (Chemotherapy)